Middletown, DE -- (SBWIRE) -- 08/30/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: CHINA CONSTRUCTION B(OTCMKTS:CICHY), CARREFOUR S.A.(OTCMKTS:CRRFY), Volt Information Sciences, Inc.(OTCMKTS:VISI), Generex Biotechnology Corporation(OTCMKTS:GNBT).
CHINA CONSTRUCTION B(OTCMKTS:CICHY) ended higher +0.81% and complete the day at $14.62. The total number of shares changed hands during the day was 54,291. After opening at $14.62, the stock hit as high as $14.75. However, it traded between $12.73 and $17.41 over the last twelve months.
China Construction Bank Corporation, together with its subsidiaries, provides corporate and personal banking, and treasury services. Its Corporate Banking segment offers various financial products and services to corporations, government agencies, and financial institutions.
For How Long CICHY will Fight for Profitability? Read This Trend Analysis report
CARREFOUR S.A.(OTCMKTS:CRRFY) closed yesterday at $6.28, a +3.72% increase. Around 354,680 shares were traded, beating an-average trading volume of 121,190 shares. The company is now valued at around $21.90 billion.
Carrefour SA operates hypermarkets, supermarkets, convenience stores, cash and carry stores, and hypercash stores worldwide. The company also operates food and non-food e-commerce Websites. Its hypermarkets offer food products; and non-food products comprising clothing products,
For How Long CRRFY Gloss will Attract Investors? Find out via this report
Generex Biotechnology Corporation(OTCMKTS:GNBT) moved -0.61 percent lower at $0.0328 and traded between $0.03 and $0.03 after opening the day at $0.03. Its performance over the last five days remained -10.87%, which stands at -14.58% for a month. Going back further than one month, 1-year performance after recent close was 31.2%.
Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
Why Should Investors Buy GNBT After the Recent Fall? Just Go Here and Find Out
Volt Information Sciences, Inc.(OTCMKTS:VISI) shares fall, losing -2.10 percent to close at $7.00. The stock is up around 12% this year and 6.87% for the last 12 months. Around 98,287 shares changed hands yesterday, higher from an-average trading volume of 14,043 shares.
Volt Information Sciences, Inc. provides staffing services, and telecommunications and information solutions. The Company is organized in two businesses: Staffing Services and Telecommunications and Information Solutions. Staffing services segment provides a range of employee staffing services to a range of customers throughout North America, Europe and Asia/Pac, and has expanded operations in Latin America.
Will VISI Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)